Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UU Research Probes Alzheimer’s/Diabetes Links

21.10.2005


Researchers at the University of Ulster have found that drugs being developed to combat diabetes could also prevent nerve degeneration caused by Alzheimer’s disease.

Neurobiologist Dr Christian Holscher, who heads the Alzheimer Research Group at the University’s Coleraine campus, has teamed up with the University’s internationally renowned diabetes research group to investigate links between two diseases.

Recent research has shown a surprising link between Alzheimer’s and diabetes, two of the major health challenges facing society today. According to Dr Holscher modern lifestyle promotes the development of type 2 diabetes, which in turn could drastically increase the number of people to develop Alzheimer’s disease as people with type 2 diabetes are much more likely to develop the disease than healthy people of the same age.



“Overeating, high fat and sugar content in the diet combined with little physical activity all increase the chances of a person developing type 2 diabetes. The number of people with this form of diabetes has rocketed in the last 10 years,” says Dr Holscher. “Type 2 diabetes used to be called ‘old age diabetes’, but now even children as young as 10 years old develop it. In the next decade, it is estimated that the number of obese people will double and that one in five will be considered obese or heavily overweight.”

He continued: “Blood sugar levels are high in type 2 diabetes patients because the cells do not respond to insulin any more. Insulin is the hormone that controls the levels of blood sugar and stimulates cell growth and repair.

“Alzheimer’s causes the brain to slowly degenerate. In the brains of patients with Alzheimer’s, proteins called beta-amyloid and tau accumulate and start to aggregate to lumps called plaques and tangles. Though all people have this protein, it appears to aggregate at alarming rates in some people and this can kill neurons over time,” explained Dr Holscher.

Recent research has shown that developing type 2 diabetes makes neurons in the brain more vulnerable to attack and to damaging influences. Protective mechanisms in the brain lose their effectiveness in protecting neurons and promoting growth and repair.

UU researchers are now investigating whether the drugs being developed to combat diabetes could also benefit the defence mechanisms of the brain against the neurodegeneration that develops in people suffering from Alzheimer’s Disease.

Standard drugs given to diabetic patients do not enter the brain so the research team at UU has developed new techniques to test novel drugs on brain activity. Dr Holscher says he is very encouraged by recent research results.

“We have found that novel diabetes drugs not only improve type 2 diabetes but that they also have a powerful effect on neurons to help fight off the damaging effects of beta-amyloid proteins and plaques.

This research could pave the way to developing new drugs that are specific for the protection of the brain of diabetic people, said Dr Holscher.

David Young | alfa
Further information:
http://www.ulster.ac.uk/

More articles from Health and Medicine:

nachricht Electrical 'switch' in brain's capillary network monitors activity and controls blood flow
27.03.2017 | Larner College of Medicine at the University of Vermont

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>